drugset
drugset / Trial / NCT02089425

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

NCT02089425 ↗

Phase 3 Terminated 384 enrolled Kowa Research Institute, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.

Timeline

Start
2014-04
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule 0.5 % —

Indications

No indication recorded.